Navigation Links
Signal Genetics Announces Partnership with Array BioPharma to Advance a Multiple Myeloma Program Backed by Companion Diagnostics
Date:9/22/2010

NEW YORK, Sept. 22 /PRNewswire/ -- Signal Genetics, a privately held predictive genetic testing company focused on oncology, today announced the company will work with Array BioPharma to help push forward both companies' goals of markers for patient selection, helping bring personalized medicine and companion diagnostics to patients with multiple myeloma, a cancer of the bone marrow and antibody producing cells.

Signal Genetics' groundbreaking MyPRS™ genomic testing platform will be used to further a current research program of Array BioPharma in multiple myeloma. The MyPRS™ results will provide Array BioPharma with genetic information from patient samples in two upcoming clinical studies with Array's novel proprietary drug.  This research may lead to the development of superior and personalized treatment options for myeloma patients.  

"This partnership is a natural fit for Signal Genetics. In the healthcare industry there is a sprint to offer companion diagnostic platforms with truly personalized medicine. This partnership plants us, and Array BioPharma, at the forefront of innovation in the arena of personalized medicine in multiple myeloma," stated Joe Hernandez, President and Chief Executive.

About Signal Genetics

Signal Genetics is a privately held predictive genetic testing company focused on oncology. The goal of Signal Genetics is to provide cancer patients with their correlated predictive outcome of disease type and odds of relapse, and guide physicians to the optimal treatment regimen based on their specific genetic expression profile. Additional information is available at www.signalgenetics.com.


'/>"/>
SOURCE Signal Genetics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
2. Signalife to Issue Breaking News Regarding Vianale & Vianale Tomorrow
3. Signalife Announces Anticipated Date of Transition to OTCBB
4. Signalife Announces Reverse Stock Split, Preferred Stock Dividend and $5 Million Investment
5. Revealing the regulating mechanism behind signal transduction in the brain
6. Gene Signal Enters Phase III Clinical Tests for the Prevention of Corneal Graft Rejection
7. Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling
8. Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product Development
9. Cellzome Technology Used to Unravel Novel Regulatory Mechanism in Cancer Signaling Pathway
10. Clinical Remissions in Three Otherwise Intractable Cancers Signal the Progress of Targeted Genetic Medicine
11. TRINAMIC Teams with Actel's SmartFusion™ Intelligent Mixed Signal FPGAs for Motion Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... BioTech News Coverage: Progress made ... of studies and trials.  Companies in focus are: GenSpera ... LLY ), Gilead Sciences Inc. (NASDAQ: ... and Arena Pharmaceuticals Inc. (NASDAQ: ARNA) GenSpera, ... for the treatment of cancer, announced that the United ...
(Date:9/19/2014)... Paul, Minnesota (PRWEB) September 19, 2014 ... from related food industries will gather October 5–8, ... at the Rhode Island Convention Center in Providence, ... will feature the work of food scientists, chemists, ... quality control, and food production management. To date, ...
(Date:9/19/2014)... ROCKLAND, Massachusetts , September 19, 2014 ... with the 53rd European Society for Paediatric Endocrinology (ESPE) ... advancement of science and medical research in the field ... of Merck KGaA, Darmstadt, Germany , ... Growth Innovation (GGI) for 2014. The awards were announced ...
(Date:9/18/2014)... BELLINGHAM, Washington, USA (PRWEB) September 18, 2014 ... of Representatives of a bill designed to stimulate development ... high-value jobs is being praised by leaders of ... The bill, the Revitalizing American Manufacturing and Innovation (RAMI) ... vote. The bill’s authors have said they are optimistic ...
Breaking Biology Technology:Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 2Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 3Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 4Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 5Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 6Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent 7Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3
... , , , ... NBIX ) announced today that the Company will report its second ... July 29, 2009. Neurocrine will then host a live conference ... update Thursday morning, July 30, 2009 at 8:30 a.m. Eastern Daylight Time ...
... , , , ... Group , , NEW ... non-invasive molecular oncology diagnostics to aid in early cancer detection ... named Chief Operating Officer. As COO, Zdechlik will be ...
... ... the keynote address , ... Parsipany, NJ (PRWEB) July 22, 2009 -- Vistaar Technologies, Inc. Vistaar ... announced the company will partner with the Professional Pricing Society (PPS), the world,s only ...
Cached Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results 2Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer 2Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners 2Vistaar and the Professional Pricing Society Partner to Present Premier Symposium for Pricing Practitioners 3
(Date:9/19/2014)... sense of fairness did not evolve for the sake ... the benefits of continued cooperation, so say Frans de ... review article about inequity aversion (IA), which is defined ... is published in Science . , Their ... IA-related studies to address their hypothesis that it is ...
(Date:9/18/2014)... University researchers have developed a unique method to use ... in rural areas. , The first microbe-powered, self-sustaining ... quick way to clean up waste from large farming ... , Professor Haluk Beyenal and graduate student Timothy ... discuss the system in the online edition of ...
(Date:9/18/2014)... New research into the Crimean-Congo hemorrhagic fever virus (CCHFV), ... in humans similar to that caused by Ebolavirus, has ... discovery has the potential to lead to novel targets ... The research, reported in a paper published today in ... scientists at the Texas Biomedical Research Institute and their ...
Breaking Biology News(10 mins):Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3Researchers develop unique waste cleanup for rural areas 2Research milestone in CCHF virus could help identify new treatments 2
... virus called cytomegalovirus (CMV), which most commonly affects people ... patients who have no immune-system problems, University of Washington ... longer hospital and intensive-care unit (ICU) stays independent of ... in JAMA , the Journal of the ...
... stem cells originate in a different part of the brain ... produce new brain cells to replace those lost to disease ... Evidence strongly shows that the true stem cells in ... ventricles in the brain and spinal cord, rather than cells ...
... In the life of a cell, the response to DNA damage ... commit suicide, or grow uncontrollably, a route leading to cancer. In ... Cell , scientists at NYU Langone Medical Center have identified a ... targets proteins for disposal. The finding points to a new pathway ...
Cached Biology News:CMV infections affect more than just patients with compromised immune systems, researchers find 2Adult stem cells activated in mammalian brain 2Adult stem cells activated in mammalian brain 3A new cellular pathway linked to cancer is identified by NYU researchers 2
... cassette is designed to allow ampicillin selection ... gb2 driving the gene for ampicillin resistance ... Em7 promoter. It mediates higher transcription efficiency ... synthetic polyadenylation signal terminates the ampicillin expression. ...
... PRO S-7 stirrers deliver accurate ... channels fluids away from internal ... easy-to-use controls which allow users ... ceramic tops feature a chemical ...
... Agencourt AMPure is a magnetic ... requires no sample transfer, centrifugation ... purifies small and large PCR ... 384-well microplates. Agencourt AMPure can ...
... These 1.5L PYREX trypsinizing ... homogenous tissue samples into cell ... proteins. Heavy beaded neck accepts ... enhance vigorous agitation. • Height ...
Biology Products: